trending Market Intelligence /marketintelligence/en/news-insights/trending/0ctQtT0wbg0DeoTiQvp2KA2 content esgSubNav
In This List

InVivo Therapeutics CEO resigns

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


InVivo Therapeutics CEO resigns

InVivo Therapeutics Holdings Corp. CEO Mark Perrin is resigning, to be replaced by Richard Toselli on an acting basis.

Ann Merrifield will replace Perrin as the chair of the company's board. Merrifield was previously the company's lead director.

Toselli currently serves as InVivo's chief medical officer and he will continue to do so.